Matches in Wikidata for { <http://www.wikidata.org/entity/Q91066751> ?p ?o ?g. }
Showing items 1 to 53 of
53
with 100 items per page.
- Q91066751 description "artículu científicu espublizáu n'ochobre de 2019" @default.
- Q91066751 description "scientific article published on 21 October 2019" @default.
- Q91066751 description "wetenschappelijk artikel" @default.
- Q91066751 description "наукова стаття, опублікована 21 жовтня 2019" @default.
- Q91066751 name "Clinical validation of reduction in cocaine frequency level as an endpoint in clinical trials for cocaine use disorder" @default.
- Q91066751 name "Clinical validation of reduction in cocaine frequency level as an endpoint in clinical trials for cocaine use disorder" @default.
- Q91066751 type Item @default.
- Q91066751 label "Clinical validation of reduction in cocaine frequency level as an endpoint in clinical trials for cocaine use disorder" @default.
- Q91066751 label "Clinical validation of reduction in cocaine frequency level as an endpoint in clinical trials for cocaine use disorder" @default.
- Q91066751 prefLabel "Clinical validation of reduction in cocaine frequency level as an endpoint in clinical trials for cocaine use disorder" @default.
- Q91066751 prefLabel "Clinical validation of reduction in cocaine frequency level as an endpoint in clinical trials for cocaine use disorder" @default.
- Q91066751 P1433 Q91066751-2CB2C668-C5F5-4E20-A85B-17D35F7BF649 @default.
- Q91066751 P1476 Q91066751-7DD95D40-31E6-470F-898E-A70924107895 @default.
- Q91066751 P2093 Q91066751-05EAF85B-406A-4DEF-8AF4-59E77DFB7E75 @default.
- Q91066751 P2093 Q91066751-4C162327-B811-47D2-A267-82854FEED105 @default.
- Q91066751 P2093 Q91066751-4D84C80E-82D1-43AB-B72A-2F685A0518F2 @default.
- Q91066751 P2093 Q91066751-801912ED-5928-4086-9D53-21D43B27554B @default.
- Q91066751 P2093 Q91066751-ABB7A1A4-76D9-4139-911E-9039203A9F33 @default.
- Q91066751 P2093 Q91066751-AE767757-35F0-4059-A0D8-AE81131136CE @default.
- Q91066751 P2093 Q91066751-B7B3D4F5-364B-4949-9875-DFEA9C8A2E7A @default.
- Q91066751 P2093 Q91066751-BEDC14FF-0BB4-4B2A-929F-8BA62088C59D @default.
- Q91066751 P2093 Q91066751-CCF0C7C2-9CCF-4A0F-AD97-AB31D92CBAA9 @default.
- Q91066751 P2093 Q91066751-E08947D3-2FD2-40B3-8A89-2FC003C543E2 @default.
- Q91066751 P2093 Q91066751-F02C3675-496A-4774-9041-A424E019FB2B @default.
- Q91066751 P304 Q91066751-BA51F827-C58F-4CA0-A8C4-3DF63FA9B8D1 @default.
- Q91066751 P31 Q91066751-E46821E5-C16B-4214-B8E6-2614191CF864 @default.
- Q91066751 P356 Q91066751-A2906471-CD69-430E-B356-C07D32F3EBDD @default.
- Q91066751 P478 Q91066751-FE3C2DFA-51C6-4C8F-9827-B3BD68A5CC06 @default.
- Q91066751 P577 Q91066751-82362D42-59F7-4008-B64B-D40B98DA2F9F @default.
- Q91066751 P698 Q91066751-7D101CA0-A2E2-4BEC-A503-22352D5E9A26 @default.
- Q91066751 P921 Q91066751-F2A2D907-C717-4063-AB4E-183C713BB349 @default.
- Q91066751 P356 J.DRUGALCDEP.2019.107648 @default.
- Q91066751 P698 31677490 @default.
- Q91066751 P1433 Q5308875 @default.
- Q91066751 P1476 "Clinical validation of reduction in cocaine frequency level as an endpoint in clinical trials for cocaine use disorder" @default.
- Q91066751 P2093 "André Q C Miguel" @default.
- Q91066751 P2093 "Brian D Kiluk" @default.
- Q91066751 P2093 "Charla Nich" @default.
- Q91066751 P2093 "Chung Jung Mun" @default.
- Q91066751 P2093 "Corey R Roos" @default.
- Q91066751 P2093 "Elise E DeVito" @default.
- Q91066751 P2093 "Justin Mendonca" @default.
- Q91066751 P2093 "Kathleen M Carroll" @default.
- Q91066751 P2093 "Katie Witkiewitz" @default.
- Q91066751 P2093 "Sarah W Yip" @default.
- Q91066751 P2093 "Theresa A Babuscio" @default.
- Q91066751 P304 "107648" @default.
- Q91066751 P31 Q13442814 @default.
- Q91066751 P356 "10.1016/J.DRUGALCDEP.2019.107648" @default.
- Q91066751 P478 "205" @default.
- Q91066751 P577 "2019-10-21T00:00:00Z" @default.
- Q91066751 P698 "31677490" @default.
- Q91066751 P921 Q7632070 @default.